1. Repository of Kharkiv National Medical University

Browsing by Author Bilovol, O.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

А Б В Г Ґ Д Е Є Ё Ж З И І Ї Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я
or enter first few letters:  
Showing results 1 to 10 of 10
PreviewIssue DateTitleAuthor(s)
2023-03Dependence of cardiotrophin-1 on biochemical and hormonal factors in patients with comorbid pathology: arterial hypertension, type 2 diabetes mellitus and obesityДунаєва, Інна Павлівна; Біловол, Олександр Миколайович; Dunaieva, I.; Bilovol, O.
2023Dynamics of SST2 and NT-PROBNP in patients with arterial hypertension and type 2 diabetes mellitus based on combined therapy with eplerenone and trimetazidine additionBilovol, O.; Kniazkova, I.; Kirienko, O.; Kuzminova, N.; Sushetska, A.; Starenkiy, V.; Abramova, L.
2023Effect of anti-hypertensive therapy on arterial wall stiffness in patients with arterial hypertensionBilovol, O.; Kniazkova, I.; Mishchenko, V.; Zhadan, A.; Kuzminova, N.; Starenky, A.; Bogun, M.
2022Effect of eplerenone on serum level of soluble growth-stimulating receptor expressed by gene 2 in patients with arterial hypertensionBilovol, O.; Knyazkova, I.; Golovacheva, V.; Kuzminova, N.; Barbashova, V.; Molodan, D.; Bogun, N.
2022Functional condition of kidneys in patients with arterial hypertension in combination with type 2 diabetes mellitusBilovol, O.; Kniazkova, I.; Kirienko, O.; Kuzminova, N.; Golovachova, V.; Kirienko, D.; Abramova, L.
Bilovol et al_Hepatic fibrosis as an additional.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
Статья Синайко WoS 2021.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
2023Influence of ethylmethylhydroxypyridine succinate inclusion in antihypertensive therapy on the condition of the arterial wall in young patients with hypertensionBilovol, O.; Kniazkova, I.; Mishchenko, V.; Kuzminova, N.; Starenkyi, V.; Zhadan, A.; Bogun, M.
2022Soluble gene-expressed stimulating growth factor receptor 2 as a possible serum marker of diastolic dysfunction in patients with hypertensive disease and type 2 diabetes mellitusBilovol, O.; Knyazkova, I.; Kіrіenko, O.; Kuzminova, N.; Kirіenko, D.; Bogun, M.; Havryliuk, A.
Bilovol et al._Therapeutic efficacy.pdf.jpg2021Терапевтична ефективність кверцетину у пацієнтів з артеріальною гіпертензією та метаболічним синдромомBilovol, O.; Kniazkova, I.; Kuzminova, Natalia; Kirienko, O.; Abramova, L.; Gavrylyuk, A.
Showing results 1 to 10 of 10